PXMBF Paxman AB

USD 2.80 0.00 0
Icon

Paxman AB (PXMBF) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.80

0.00 (0.00)%

USD 0.05B

N/A

N/A

N/A

Icon

PXMBF

Paxman AB (USD)
COMMON STOCK | OTC
USD 2.80
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.05B

N/A

USD 2.80

Paxman AB (PXMBF) Stock Forecast

N/A

Based on the Paxman AB stock forecast from 0 analysts, the average analyst target price for Paxman AB is not available over the next 12 months. Paxman AB’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Paxman AB is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Paxman AB’s stock price was USD 2.80. Paxman AB’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -60.84% over the last year.

No recent analyst target price found for Paxman AB
No recent average analyst rating found for Paxman AB

Company Overview Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various clinics and treatment centers, and hospitals. The company has a research collaboration agr...Read More

Pirgatan 13, Karlshamn, Sweden, 374 35

88

December

USD

USA

Adjusted Closing Price for Paxman AB (PXMBF)

Loading...

Unadjusted Closing Price for Paxman AB (PXMBF)

Loading...

Share Trading Volume for Paxman AB Shares

Loading...

Compare Performance of Paxman AB Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PXMBF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Paxman AB (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SMMNY
Siemens Healthineers AG ADR 0.00 (0.00%) USD65.00B 38.97 16.64

ETFs Containing PXMBF

Symbol Name PXMBF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Paxman AB (PXMBF) Stock

Stock Target Advisor's fundamental analysis for Paxman AB's stock is Neutral.

Unfortunately we do not have enough data on PXMBF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on PXMBF's stock to indicate what its average analyst target is.

PXMBF stock's Price/Earning ratio is 106.93. Our analysis grades PXMBF stock's Price / Earning ratio at F. This means that PXMBF stock's Price/Earning ratio is above 86% of the stocks in the Medical Devices sector in the OTC exchange. Based on this PXMBF may be a overvalued for its sector.

The last closing price of PXMBF's stock was USD 2.80.

The most recent market capitalization for PXMBF is USD 0.05B.

Unfortunately we do not have enough analyst data on PXMBF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Paxman AB's stock.

As per our most recent records Paxman AB has 88 Employees.

Paxman AB's registered address is Pirgatan 13, Karlshamn, Sweden, 374 35. You can get more information about it from Paxman AB's website at https://paxmanscalpcooling.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...